Skip to main content

Table 3 Clinical biomarkers and CMR parameters at baseline and follow-up among IIM patients with CMR follow-up

From: Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy

 

Baseline (n = 28)

Follow-up (n = 28)

P* value

Biomarker

 Hct

0.40 ± 0.05

0.43 ± 0.04

0.005

 CRP (mg/L)

5.7 (2.8–17.9)

2.2 (1.8–4.1)

0.024

 ESR (mm/h)

26 (23–47)

22 (5–33)

0.064

 CK (U/L)

479 (83–1060)

106 (75–148)

0.038

 CK-MB (ng/mL)

24.7 (7.1–74.6)

2.5 (1.0–4.8)

< 0.001

 cTnT (g/L)

102 (60–480)

17 (10–67)

< 0.001

 BNP (pg/mL)

235 (72–1184)

50 (26–109)

0.007

Structural and function

 LVEDVi, ml3/m2

83.7 ± 19.4

82.3 ± 18.0

0.703

 LVESVi, ml3/m2

34.0 ± 15.3

34.3 ± 13.8

0.549

 LVmassi, g/m2

51.2 ± 12.5

45.2 ± 10.2

0.011

 LVEF, %

59.4 ± 8.7

60.5 ± 10.5

0.395

 RVEDVi, ml3/m2

81.8 ± 16.2

79.8 ± 11.6

0.279

 RVESVi, ml3/m2

39.3 ± 11.8

37.4 ± 8.0

0.073

 RVEF, %

53.2 ± 6.2

55.2 ± 6.8

0.492

Myocardial tissue characteristics

 T2w ratio

1.3 ± 0.5

1.3 ± 0.4

0.621

 LGE presence, n(%)

7 (25%)

7 (25%)

1

 LGE extent, %

11.8 ± 2.9

8.1 ± 2.0

0.239

 Native T1-myo, ms

1289 ± 53

1262 ± 59

0.013

 T2 mapping-myo, ms

44.4 ± 4.0

41.8 ± 4.2

0.001

 ECV-myo, %

30.7 ± 4.1

27.6 ± 4.4

0.001

Skeletal tissue characteristics

 Native T1-sk, ms

1268 ± 103

1154 ± 73

< 0.001

 T2 mapping-sk, ms

34.5 ± 3.5

29.7 ± 2.8

< 0.001

 ECV-sk, %

29.2 ± 11.1

21.9 ± 11.2

0.011

  1. Abbreviations: Hct hematocrit, CRP C-reactive protein, ESR erythrocyte sedimentation rate, CK creatine kinase, CK-MB creatine kinase-MB, TnT troponin T, NT-proBNP N-terminal pro b-type natriuretic peptide, LVEDVi left ventricular end-diastolic volume index, LVESVi left ventricular end-systolic volume index, LVmassi left ventricular mass index, LVEF left ventricular ejection fraction, RVEDVi right ventricular end-diastolic volume index, RVESVi right ventricular end-systolic volume index, RVEF right ventricular ejection fraction, T2W T2-weighted ratio, LGE late gadolinium enhancement, ECV extracellular volume fraction
  2. Values in bold indicate P values < 0.05
  3. P* value for comparison between baseline and follow-up characteristics among IIM patients